Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2026-11-18
BOLDBoundless Bio, Inc.Tang Kevin10%P - Purchase$2.36+103,6123,152,991+3%+$244,231
2026-11-18
SLSSellas Life Sciences Group, Inc.Burns John ThomasCFOS - Sale$19.18-3,831558,893-1%-$73,471
2026-11-18
SLSSellas Life Sciences Group, Inc.Cicic DraganSVP, Chief Development OfficerS - Sale$19.18-6,933557,361-1%-$132,961
2026-11-18
SLSSellas Life Sciences Group, Inc.Stergiou Angelos M.Pres, CEOS - Sale$19.18-26,6061,734,896-2%-$510,250
M
2026-11-19
LPCNLipocine Inc.Higuchi John W.DirP - Purchase$1.50+150,000391,365+62%+$225,225
2026-11-20
AEONAeon Biopharma, Inc.Wilson Alexander BlairCLO, CSO, Corp SecretaryP - Purchase$0.13+135,7062,318,711+6%+$17,479
2026-11-19
AEONAeon Biopharma, Inc.Sy JenniferChief Accounting OfficerP - Purchase$0.13+153,8461,655,022+10%+$19,985
2026-11-19
AEONAeon Biopharma, Inc.Bancroft Robert E.Pres, CEOP - Purchase$0.13+152,3333,329,436+5%+$19,590
2026-11-19
CRMDCormedix Inc.Blum SusanCFOP - Purchase$4.58+5,000129,315+4%+$22,900
2026-11-18
RCKTRocket Pharmaceuticals, Inc.Shah GauravCEOS - Sale$2.18-2,2161,457,5960%-$4,826
2026-11-18
RCKTRocket Pharmaceuticals, Inc.Wilson MartinGCS - Sale$2.18-677540,3360%-$1,475
D
2026-11-20
ORKAOruka Therapeutics, Inc.Quinlan Paul TGCS - Sale+OE$94.89-9,00029,995-23%-$853,986
M
2026-11-18
BBIOBridgebio Pharma, Inc.Kumar NeilCEOS - Sale$77.86-54,9805,037,460-1%-$4,280,760
D
2026-11-19
INSMInsmed IncSchaeffer Orlov S NicoleChief People Strategy OfficerS - Sale+OE$145.26-101,10041,895-71%-$14,685,602
D
2026-11-18
RYTMRhythm Pharmaceuticals, Inc.Shulman JosephChief Technical OfficerS - Sale+OE$119.91-45,92110,461-81%-$5,506,153
2026-11-18
BBOTBridgebio Oncology Therapeutics, Inc.Beltran PedroPres, CEOS - Sale$1.84-1,87041,659-4%-$3,443
2026-11-17
LEGNLegend Biotech CorpZhang IngridCEOP - Purchase$8.16+20,0001,151,860+2%+$163,200
2026-11-19
DAREDare Bioscience, Inc.Rastetter William HDirS - Sale$0.45-8590-100%-$382
2026-11-19
ANNXAnnexon, Inc.Carson William H.DirP - Purchase$3.58+34,000112,405+43%+$121,720
2026-11-18
CRMDCormedix Inc.Lefkowitz Steven WDirP - Purchase$4.53+11,500169,603+7%+$52,095
2026-11-18
IMMXImmix Biopharma, Inc.Rachman Ilya MCEO, COBP - Purchase$7.10+1,4081,143,0910%+$10,000
2026-11-18
IMMXImmix Biopharma, Inc.Morris Gabriel SCFO, PresP - Purchase$7.06+1,418743,8320%+$10,011
2026-11-18
NMADNomad Power Solutions, Inc.Holloway Michael AndrewDirP - Purchase$2.82+15,00055,000+38%+$42,300
2026-11-18
FLNAFilana Therapeutics, Inc.Anderson Robert Eugene JrDirP - Purchase$0.52+19,00027,600+221%+$9,880
2026-11-18
FLNAFilana Therapeutics, Inc.Barry RichardPres, CEOP - Purchase$0.52+44,8511,955,947+2%+$23,323
DM
2026-11-17
AVIRAtea Pharmaceuticals, Inc.Lucidi BrunoDirS - Sale+OE$3.96-29,360187,990-14%-$116,410
2026-11-19
AVIRAtea Pharmaceuticals, Inc.Polsky BruceDirS - Sale$4.03-8,750149,830-6%-$35,298
2026-11-18
CRVOCervomed Inc.Alam John JCEO, Pres, 10%P - Purchase$1.53+100,0001,596,578+7%+$152,621
2026-11-17
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale$35.85-42954,226-1%-$15,380
2026-11-17
NKTRNektar TherapeuticsZalevsky JonathanChief R, D OfficerS - Sale$35.85-1929,378-2%-$6,883
D
2026-11-19
UTHRUnited Therapeutics CorpMahon Paul AEVP, GCS - Sale+OE$565.09-8,30045,172-16%-$4,690,229
2026-11-19
KURAKura Oncology, Inc.Powl Brian T.Chief Commercial OfficerS - Sale$7.27-448112,8170%-$3,257
2026-11-17
TNGXTango Therapeutics, Inc.Ketchum John BDirS - Sale$24.08-3,33321,604-13%-$80,259
2026-11-18
BMRNBiomarin Pharmaceutical IncFriberg Gregory REVP, Chief R, D OfficerS - Sale$58.81-5,14742,585-11%-$302,711
M
2026-11-17
FBIOFortress Biotech, Inc.Rosenwald Lindsay A MdPres, CEO, COB, 10%P - Purchase$1.85+136,7234,723,564+3%+$252,583
M
2026-11-17
FBIOFortress Biotech, Inc.Jin DavidCFOP - Purchase$1.84+47,6051,700,366+3%+$87,814
D
2026-11-17
ELVNEnliven Therapeutics, Inc.Collins Helen LouiseCHIEF MEDICAL OFFICERS - Sale+OE$46.84-5,00025,000-17%-$234,203
2026-11-18
NMADNomad Power Solutions, Inc.Travaglini John FrancisDirP - Purchase$2.85+5,0005,000New+$14,270
2026-11-17
ACRVAcrivon Therapeutics, Inc.Peterson KatharineChief Accounting OfficerS - Sale$1.45-10717,926-1%-$155
D
2026-11-17
AVLNAvalyn Pharma Inc.Lazarus HowardChief Medical OfficerS - Sale+OE$27.90-13,3000-100%-$371,027
2026-11-17
ACRVAcrivon Therapeutics, Inc.Miller MaryGCS - Sale$1.45-19381,0090%-$280
D
2026-11-18
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$578.83-5,410668,728-1%-$3,131,476
2026-11-17
ACRVAcrivon Therapeutics, Inc.Gamelin ErickChief Development OfficerS - Sale$1.45-41652,176-1%-$603
2026-11-17
ACRVAcrivon Therapeutics, Inc.Devroe EricCOOS - Sale$1.45-628145,7210%-$911
2026-11-17
ACRVAcrivon Therapeutics, Inc.Blume-Jensen PeterPres, CEOS - Sale$1.45-1,7802,614,1310%-$2,581
2026-11-19
ZOMDFZomedica Corp.Powers Johnny DDirP - Purchase$0.08+175,0004,600,000+4%+$14,525
M
2026-11-17
NBPNovabridge BiosciencesHagler Mark ArnoldChief Commercial OfficerP - Purchase$0.37+230,000460,000+100%+$85,882
2026-11-17
KROSKeros Therapeutics, Inc.Newton Charles W.DirS - Sale$10.85-55111,563-5%-$5,981
2026-11-17
KROSKeros Therapeutics, Inc.Prener AnneDirS - Sale$10.83-57512,637-4%-$6,230
DM
2026-11-17
AVLNAvalyn Pharma Inc.Baranowski LynCEOS - Sale+OE$27.84-52,5000-100%-$1,461,457
D
2026-11-17
AVLNAvalyn Pharma Inc.Rhodes MelissaCOOS - Sale+OE$27.90-13,3000-100%-$371,046
D
2026-11-17
AVLNAvalyn Pharma Inc.Carlson Douglas RSee RemarksS - Sale+OE$27.90-14,8750-100%-$414,983
2026-11-17
FLNAFilana Therapeutics, Inc.Barry RichardPres, CEOP - Purchase$0.48+132,9261,911,096+7%+$63,804
M
2026-11-17
CVSICv Sciences, Inc.Cheever Charlie E III10%P - Purchase$0.01+2,030,71134,120,348+6%+$20,307
2026-11-17
PRTAProthena Corp Public Ltd CoScully William P10%P - Purchase$8.09+50,0001,743,000+3%+$404,680
2026-11-18
CLNNClene Inc.Wilcox Reed NDirP - Purchase$3.42+10,00038,756+35%+$34,240
2026-11-18
CATXPerspective Therapeutics, Inc.Williamson Robert F IIIDirP - Purchase$0.80+15,000183,744+9%+$12,000
DM
2026-11-16
AVIRAtea Pharmaceuticals, Inc.Polsky BruceDirS - Sale+OE$4.08-41,226158,580-21%-$168,095
M
2026-11-16
GRCEGrace Therapeutics, Inc.Opaleye Management Inc.10%P - Purchase$1.74+48,0603,102,904+2%+$83,435
M
2026-11-16
ANIPAni Pharmaceuticals IncLalwani NikhilPres, CEOS - Sale$71.22-5,400328,289-2%-$384,580
DM
2026-11-16
ANROAlto Neuroscience, Inc.Hanley Jr. Michael ConickCOOS - Sale+OE$27.61-75,0000-100%-$2,070,389
D
2026-11-16
CYTKCytokinetics IncBlum Robert IPres, CEOS - Sale+OE$53.53-7,500282,710-3%-$401,460
2026-11-16
SEPNSepterna, Inc.Labrucherie Gil MCFOS - Sale$41.62-20,00027,002-43%-$832,359
2026-11-18
BIVIBiovie Inc.Do Cuong VPres, CEOP - Purchase$1.00+2,50021,117+13%+$2,493
D
2026-11-17
CYTKCytokinetics IncMalik Fady IbrahamEVP Research, DevelopmentS - Sale+OE$51.78-3,500153,902-2%-$181,227
M
2026-11-16
ANABAnaptysbio, IncEcor1 Capital, LLCDir, 10%P - Purchase$45.98+374,5808,254,674+5%+$17,224,593
2026-11-17
CYTKCytokinetics IncHessekiel JeffreyChief Legal, Admin OfficerS - Sale$52.62-15,10692,837-14%-$794,878
M
2026-11-16
ROIVRoivant Sciences Ltd.Manchester Keith SDirS - Sale$38.75-1,381,76219,304,554-7%-$53,536,738
M
2026-11-16
ROIVRoivant Sciences Ltd.Gold Daniel AllenDirS - Sale$38.75-1,381,76219,304,554-7%-$53,536,738
2026-11-16
EWTXEdgewise Therapeutics, Inc.Donovan Joanne M.CMOS - Sale$45.48-8548,139-9%-$38,840
M
2026-11-16
ROIVRoivant Sciences Ltd.Qvt Financial LPDirector by DeputizationS - Sale$38.75-1,381,76219,304,554-7%-$53,536,738
2026-11-16
CRMDCormedix Inc.Kaplan MyronDirP - Purchase$4.88+25,000286,487+10%+$122,000
D
2026-11-16
PTCTPtc Therapeutics, Inc.Boulding Mark ElliottEVP, CLOS - Sale+OE$61.88-2,812105,272-3%-$174,013
D
2026-11-17
RYTMRhythm Pharmaceuticals, Inc.Jean ChristopheDirS - Sale+OE$109.66-10,00011,712-46%-$1,096,550
D
2026-11-17
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$580.43-9,500668,728-1%-$5,514,046
D
2026-11-17
ASNDAscendis Pharma A/SPedersen Anni Lotte Kirstine SonderbjergEVP, Chief Admin OfficerS - Sale+OE$263.89-20,00019,460-51%-$5,277,720
2026-11-16
LRMRLarimar Therapeutics, Inc.Clayton RussellChief Medical OfficerP - Purchase$3.01+3,32274,765+5%+$9,999
2026-11-16
VRTXVertex Pharmaceuticals Inc / MaThornberry NancyDirS - Sale$547.86-1,0001,109-47%-$547,860
2026-11-16
VRTXVertex Pharmaceuticals Inc / MaBhatia Sangeeta N.DirS - Sale$547.86-2714,653-6%-$148,470
2026-11-17
RPRXRoyalty Pharma PlcHite ChristopherEVP, COB, PartneringS - Sale$68.15-100,000200,723-33%-$6,814,710
M
2026-11-16
RPRXRoyalty Pharma PlcCoyne Terrance P.EVP, CFOS - Sale$68.81-257,12250,390-84%-$17,693,642
2026-11-16
RPRXRoyalty Pharma PlcUrist MarshallEVP, Research, InvestmentsS - Sale$69.50-25,000149,361-14%-$1,737,490
M
2026-11-16
REGNRegeneron Pharmaceuticals, Inc.Sing George LDirS - Sale$958.97-2,00025,297-7%-$1,917,945
D
2026-11-16
ARQTArcutis Biotherapeutics, Inc.Welgus Howard G.DirS - Sale+OE$28.16-4,72834,573-12%-$133,140
2026-11-16
FLNAFilana Therapeutics, Inc.Barry RichardPres, CEOP - Purchase$0.47+440,2061,778,170+33%+$206,897
D
2026-11-16
AMPHAmphastar Pharmaceuticals, Inc.Peters William JCFO, EVP, TreasurerS - Sale+OE$29.99-11,000167,076-6%-$329,890
2026-11-16
FLNAFilana Therapeutics, Inc.Schoen EricCFOP - Purchase$0.42+20,00031,500+174%+$8,400
2026-11-16
REGNRegeneron Pharmaceuticals, Inc.McCourt MarionEVP CommercialS - Sale$960.26-56610,524-5%-$543,504
2026-11-18
ALTAltimmune, Inc.Menziuso Richard ThomasPrincipal Accounting OfficerP - Purchase$1.42+10,00010,000New+$14,187
D
2026-11-17
REGNRegeneron Pharmaceuticals, Inc.Murphy Andrew JCo-Chief Scientific OfficerS - Sale+OE$957.76-5,01151,193-9%-$4,799,336
2026-11-16
FLNAFilana Therapeutics, Inc.Cook Robert ChristopherCOO,Legal OfficerP - Purchase$0.46+121,575135,300+886%+$55,925
2026-11-16
KURAKura Oncology, Inc.Doyle Thomas JamesSVP, Finance, AccountingS - Sale$7.44-4,697138,581-3%-$34,946
M
2026-11-16
KURAKura Oncology, Inc.Leoni MollieChief Medical OfficerS - Sale$7.45-41,25099,845-29%-$307,122
M
2026-11-16
KURAKura Oncology, Inc.Powl Brian T.Chief Commercial OfficerS - Sale$7.45-24,450113,265-18%-$182,061
2026-11-16
KURAKura Oncology, Inc.Bair Teresa BrophyGCS - Sale$7.44-8,601178,401-5%-$63,991
M
2026-11-16
KURAKura Oncology, Inc.Ford KathleenCOOS - Sale$7.45-10,710132,276-7%-$79,756
2026-11-16
IRWDIronwood Pharmaceuticals IncGaskins Tammi LChief Commercial OfficerS - Sale$4.81-5,919344,431-2%-$28,470
D
2026-11-18
ZYMEZymeworks Inc.Platshon ScottEVP, Chief Business OfficerS - Sale+OE$24.95-15,29221,745-41%-$381,535
2026-11-17
CATXPerspective Therapeutics, Inc.Williamson Robert F IIIDirP - Purchase$0.84+25,000168,744+17%+$20,950
M
2026-11-16
BOLTBolt Biotherapeutics, Inc.Coastlands Capital LP10%P - Purchase$5.84+53,094515,510+11%+$309,922

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top